ATE149310T1 - Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz - Google Patents

Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz

Info

Publication number
ATE149310T1
ATE149310T1 AT92921102T AT92921102T ATE149310T1 AT E149310 T1 ATE149310 T1 AT E149310T1 AT 92921102 T AT92921102 T AT 92921102T AT 92921102 T AT92921102 T AT 92921102T AT E149310 T1 ATE149310 T1 AT E149310T1
Authority
AT
Austria
Prior art keywords
formulation
eye
fluorescently labelled
thin film
cornea
Prior art date
Application number
AT92921102T
Other languages
English (en)
Inventor
Abhay Joshi
David Meadows
Jerry Paugh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE149310T1 publication Critical patent/ATE149310T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/13—Ophthalmic microscopes
    • A61B3/135—Slit-lamp microscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
    • A61B3/1241—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes specially adapted for observation of ocular blood flow, e.g. by fluorescein angiography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92921102T 1991-09-13 1992-09-08 Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz ATE149310T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/759,530 US5323775A (en) 1991-09-13 1991-09-13 Diagnostic method for determining precorneal retention time of ophthalmic formulations

Publications (1)

Publication Number Publication Date
ATE149310T1 true ATE149310T1 (de) 1997-03-15

Family

ID=25056002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921102T ATE149310T1 (de) 1991-09-13 1992-09-08 Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz

Country Status (7)

Country Link
US (2) US5323775A (de)
EP (1) EP0603338B1 (de)
AT (1) ATE149310T1 (de)
AU (1) AU2670892A (de)
DE (1) DE69217969T2 (de)
ES (1) ES2100362T3 (de)
WO (1) WO1993005699A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101290B (pt) * 1993-06-18 2000-10-31 Fernandes Jose Guilherme Da Cu Fluorometro para medicao da concentracao de fluoroforos de localizacao ocular
US5553617A (en) * 1995-01-20 1996-09-10 Hughes Aircraft Company Noninvasive method and apparatus for determining body chemistry
US6179779B1 (en) 1997-12-22 2001-01-30 Ffhk Development Company Llc Replaceable prism system for applanation tonometer
US6736778B2 (en) 1997-12-22 2004-05-18 Francis Y. Falck, Jr. Replaceable prism for applanation tonometer
JP2004500197A (ja) 2000-02-08 2004-01-08 コーネル　リサーチ　ファンデーション　インコーポレーテッド 光ファイバーを通じた蛍光分光用の多光子励起
AU2002251682A1 (en) * 2000-11-02 2002-08-28 Cornell Research Foundation, Inc. In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease
JP4823906B2 (ja) * 2003-08-19 2011-11-24 コーネル リサーチ ファンデーション インコーポレーティッド 多光子顕微鏡観察、分光法、および内視鏡観察などの生物学的用途のための光ファイバー送集光システム
US20070089231A1 (en) * 2005-10-24 2007-04-26 Fendall, Inc. Emergency eyewash station having a peircing mechanism to puncture a sealed fluid bladder
WO2007050524A1 (en) * 2005-10-24 2007-05-03 Sperian Eye & Face Protection, Inc. Pump assembly for an emergency eyewash station
WO2007050525A1 (en) * 2005-10-24 2007-05-03 Sperian Eye & Face Protection, Inc. Emergency eyewash station having an expandable bellows waste collection system
US8316477B2 (en) * 2005-10-24 2012-11-27 Sperian Eye & Face Protection, Inc. Cartridge assembly for a self-contained emergency eyewash station
US8313472B2 (en) * 2006-03-15 2012-11-20 Sperian Eye & Face Protection, Inc. a Delaware corporation Emergency eyewash station and dispensing structure therefor
AU2008247423B2 (en) 2007-05-04 2013-10-31 Abbott Medical Optics Inc. Methods and devices for measuring tear film and diagnosing tear disorders
US7989404B2 (en) * 2008-02-11 2011-08-02 Clearwater International, Llc Compositions and methods for gas well treatment
GB2493568B (en) * 2011-08-09 2018-08-29 Zeiss Carl Meditec Ag Opthalmologic composition comprising an aqueous solution of at least one viscoelastic polysaccharide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
US4120792A (en) * 1977-08-15 1978-10-17 Thiokol Corporation Combined filter and incinerator
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4597965A (en) * 1979-06-06 1986-07-01 Holles Laboratories, Inc. Method and composition for controlling corneal hydration
US4412543A (en) * 1981-04-09 1983-11-01 Xanar, Inc. Apparatus for determining the concentration of a fluorescent material in an eye
US5025785A (en) * 1982-09-10 1991-06-25 Weiss Jeffrey N Diabetes detection method
US4883351A (en) * 1982-09-10 1989-11-28 Weiss Jeffrey N Apparatus for the detection of diabetes and other abnormalities affecting the lens of the eye
US4895159A (en) * 1982-09-10 1990-01-23 Weiss Jeffrey N Diabetes detection method
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4573778A (en) * 1983-03-16 1986-03-04 Boston University Aqueous fluorophotometer
US4594326A (en) * 1983-05-09 1986-06-10 Wade Stephen E Time-integrated measurement for determining substances in biological fluids
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4711540A (en) * 1984-01-04 1987-12-08 Tokyo Kogaku Kikai Kabushiki Kaisha Eye disease inspecting instrument
US4711541A (en) * 1984-02-02 1987-12-08 Tokyo Kogaku Kikai Kabushiki Kaisha Slit lamp and accessory device thereof
SE454842B (sv) * 1984-11-01 1988-06-06 Pharmacia Ab Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne
US4702576A (en) * 1985-09-27 1987-10-27 Cambridge Instruments Inc. Ocular scattering analyzer
DE3542167A1 (de) * 1985-11-29 1987-06-04 Wolfgang Prof Dr Lohmann Verfahren zur messung der augen-linsen-truebung und anordnung zur durchfuehrung des verfahrens
CH671329A5 (de) * 1986-01-21 1989-08-31 Interzeag Ag
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4842401A (en) * 1987-06-15 1989-06-27 The Board Of Trustees Of The Leland Stanford Jr. University Eye diagnosis process
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same

Also Published As

Publication number Publication date
EP0603338A1 (de) 1994-06-29
DE69217969D1 (de) 1997-04-10
EP0603338B1 (de) 1997-03-05
US5323775A (en) 1994-06-28
US5634458A (en) 1997-06-03
ES2100362T3 (es) 1997-06-16
WO1993005699A1 (en) 1993-04-01
AU2670892A (en) 1993-04-27
DE69217969T2 (de) 1997-06-12

Similar Documents

Publication Publication Date Title
ATE149310T1 (de) Methode und lösung zur bestimmung der wirkungsdauer einer auf die hornhaut aufgebrachten substanz
ATE76288T1 (de) Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung.
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
ATE133336T1 (de) Verwendung von rapamycin zur herstellung eines arzneimittels zur behandlung von augenentzündungen
ATE61935T1 (de) Verfahren zur herstellung von mikrokapseln.
FR2422402A1 (fr) Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
ATE29207T1 (de) Beleuchtungseinrichtung zum sichtbaren nachweis von karies.
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
BG46600A3 (en) Method for preparing derivatives of dihydrobenzofuran and of chromancarboxamides
ATA540478A (de) Verfahren zur herstellung von optisch aktiven alpha-hydroxycarbonsaeuren
AT363936B (de) Verfahren zur herstellung von neuen cyproheptadinderivaten und von deren pharmazeutisch verwendbaren salzen sowie optischen isomeren
DE3764700D1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
SE8801710L (sv) New ophtalmological composition of matter
PT88383A (pt) Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
ATA147676A (de) Verfahren zur herstellung von reiner traubensaure und von mesoweinsaure
DE69115687D1 (de) Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese
DE3862017D1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
FR2390157A1 (fr) Produit et procede pour le traitement de l'ivoire dentaire par le cerium
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE49402T1 (de) Verfahren zur herstellung von zirkoniumcarboxylat.
ATE122886T1 (de) Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht.
DE3881484D1 (de) Optisch aktive produkte von 20,21-dinoreburnamenin-derivaten, verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties